FDA Adverse Event Death Summary report: N

HEMOCHRON SIGNATURE MICROCOAGULATION SYSTEM

MDR report key: 1897824 · Received October 4, 2010

Report

Report Number
2248721-2010-00160
Event Type
Death
Date Received
October 4, 2010
Date of Event
October 1, 2010
Report Date
October 7, 2010
Manufacturer
INTERNATIONAL TECHNIDYNE CORP.
Product Code
JPA
PMA / PMN Number
K050016
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THIS MDR SUBMITTED ON 11/04/2010. REFERENCES ITC COMPLAINT CASE (B)(4). PATIENT DEATH WAS NOT DUE TO THE INSTRUMENT IN THIS REPORT. CUSTOMER INDICATED POST EVENT QUALITY CONTROL RESULTS DEMONSTRATED PROPER PERFORMANCE. MANUFACTURER AWAITING PRODUCT RETURN FOR FURTHER COMPLAINT EVALUATION. THERE ARE 2 STAGES TO DIC. IN THE EARLY STAGE, THERE IS WIDESPREAD ACTIVATION OF CLOTTING FACTORS. AT THIS STAGE, ACT IS EXPECTED TO BE VERY SHORT. AS DIC PROGRESSES, CLOTTING FACTORS ARE CONSUMED AND ANTI-CLOTTING FACTORS BECOME ACTIVATED. AT THIS STAGE, ACT IS TYPICALLY MARKEDLY PROLONGED. THE ACTS OBSERVED IN THIS COMPLAINT ARE CONSISTENT WITH THE 2 PHASES OF DIC, AND THEREFORE, THE (B)(4) ITC'S MEDICAL ADVISORY BOARD STATES THE INSTRUMENT PERFORMED AS EXPECTED. ITC COMPLAINT CASE ADDITIONAL REFERENCE: CASE (B)(4), MDR #2248721-2010-00150; CASE (B)(4), MDR #2248721-2010-00158; CASE (B)(4), MDR #2248721-2010-00159. CUVETTE LOT #'S: G0JAC204, G0JAC118, E0JAC143. ITC HAS REQUESTED ALL DATA REQUIRED FOR FORM 3500A.

Description of Event or Problem · 1

DEVICE 4 OF 4. CUSTOMER REPORTED SEVERAL RESULTS: OUTSIDE-REPORTABLE-RANGE-LOW AND LOW AND HIGH ACT RESULTS WITH THE SIGNATURE ELITE INSTRUMENT. TESTING TIME POINTS NOT SPECIFIED AND SPECIFIC INSTRUMENTS AND CUVETTE LOT NUMBERS NOT IDENTIFIED. NOTE: ONE MDR REPORTED FOR EACH SYSTEM SERIAL NUMBER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 HEMOCHRON SIGNATURE MICROCOAGULATION SYSTEM SIGNATURE INST JPA INTERNATIONAL TECHNIDYNE CORP. ELITE

Patients

Seq Age Sex Outcome Treatment
1 67 YR Death G0JAC118,| E0JAC143.| CUVETTE: LOT #G0JAC204,